Publications of Marc Hein
All genres
Journal Article (1)
2023
Journal Article
Hein, M., Dogra, T., Kazenmaier, D., , Genzel, Y., & (2023)Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactorsFrontiers in Bioengineering and Biotechnology, 11, 1076524doi: 10.3389/fbioe.2023.1076524.
, , Talk (2)
2022
Talk
Hein, M., Chawla, A., , , , , , Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvestingPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.
Talk
Hein, M., Dogra, T., , , Genzel, Y., , , , , , , Kupke, S. Y., & Reichl, U.Influenza A Virus-Derived Defective Interfering Particles for Antiviral TreatmentPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Poster (4)
2022
Poster
Hein, M., Chawla, A., , , , , Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivationPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Poster
Kupke, S. Y., Hein, M., , , Marichal-Gallardo, P., , , , , & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.
2019
Poster
Hein, M.Producing a new class of defective interfering particles as antiviralPresented at: 26th ESACT MeetingKopenhagen, Denmark, May 5, 2019.
Poster
Hein, M.Production of a novel class of influenza A virus-derived defective interfering particle as an antiviral agentPresented at: 14th PEACeRhode Island, USA, September 22, 2019.
Thesis - PhD (1)
2022
Thesis - PhD
Hein, M. (2022)Cell culture-based production of influenza A virus-derived defective interfering particlesPhD Thesis, Otto-von-Guericke-Universität, Magdeburgdoi: 10.25673/88117.